Oncolytics Biotech
ONCY
NASDAQ
IPO2001
about ONCY
Oncolytics Biotech develops innovative cancer treatments, including a proprietary interferon alfa-based therapeutic platform designed to target and treat cancers while sparing healthy cells.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $1.01 | $1.04 | $1.00 | $108.68M | 859.23K |